SCHEMBL2903805

SCHEMBL2903805

COc1cc(Cl)ccc1-c1cn(CCCNc2ccc([N+](=O)[O-])c(N)n2)cc1C(=O)N[C@@H](C)CO

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.41
GSK3A P49840 3/20 0.41
ALDH1A1 P00352 5/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
CDK1 P06493 2/20 0.38
CCNB2 O95067 1/20 0.37
CCNB1 P14635 1/20 0.37
CCNB3 Q8WWL7 1/20 0.37
MEN1 O00255 1/20 0.36
POLB P06746 1/20 0.36
KMT2A Q03164 1/20 0.36
SCN10A Q9Y5Y9 1/20 0.35
PTAFR P25105 1/20 0.34
MAPT P10636 2/20 0.33
HTT P42858 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.33
F11 P03951 1/20 0.33
KLKB1 P03952 1/20 0.33
CNR1 P21554 1/20 0.33
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2904789 0.92 GSK3B (0.48) GSK3BGSK3AALDH1A1SMN1; SMN2CDK1
SCHEMBL12892551 0.92 GSK3B (0.48) GSK3BGSK3AALDH1A1SMN1; SMN2CDK1
SCHEMBL2910831 0.92 GSK3B (0.48) GSK3BGSK3AALDH1A1SMN1; SMN2CDK1
SCHEMBL2912215 0.90 GSK3B (0.42) GSK3BGSK3AALDH1A1SMN1; SMN2CDK1
SCHEMBL2905208 0.90 GSK3B (0.42) GSK3BGSK3AALDH1A1SMN1; SMN2CDK1
SCHEMBL2910067 0.89 GSK3B (0.47) GSK3BGSK3AALDH1A1SMN1; SMN2CDK1
SCHEMBL2908168 0.89 GSK3B (0.42) GSK3BGSK3AALDH1A1SMN1; SMN2CDK1
SCHEMBL2908086 0.89 GSK3B (0.47) GSK3BGSK3AALDH1A1SMN1; SMN2CDK1
SCHEMBL2910371 0.88 ALDH1A1 (0.41) GSK3BGSK3AALDH1A1SMN1; SMN2CDK1
SCHEMBL2911532 0.88 ALDH1A1 (0.41) GSK3BGSK3AALDH1A1SMN1; SMN2CDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1537099-B1 PYRROLE BASED INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-11 EP disclosed